Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Depreciation & Amortization (CF) (2019 - 2025)

Biodesix's Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 4.28% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $5.7 million, down 1.82%, while the annual FY2025 figure was $5.7 million, 1.78% down from the prior year.
  • Depreciation & Amortization (CF) reached $1.4 million in Q4 2025 per BDSX's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q3 2024 to a low of $746000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $1.1 million, with a median of $903000.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): decreased 13.55% in 2023, then soared 90.92% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $855000.0 in 2021, then rose by 5.03% to $898000.0 in 2022, then increased by 8.8% to $977000.0 in 2023, then soared by 48.31% to $1.4 million in 2024, then fell by 4.28% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Depreciation & Amortization (CF) are $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).